Logo image
Se connecter
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression
Article de revue   Avec comité de lecture

Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression

Thomas Decaens, Carlo Barone, Eric Assenat, Martin Wermke, Angelica Fasolo, Philippe Merle, Jean-Frédéric Blanc, Véronique Grando, Angelo Iacobellis, Erica Villa, …
British journal of cancer, Vol.125(3), pp.465-465
03/08/2021
PMID: 34079081

Indicateurs

1 Consultations de la notice

Détails

Logo image